Concerta

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

CognitionMemoryAttention Deficit Hyperactivity Disorder

191 competitors in Cognition

#DrugCompanyPhaseTrials

1

Vivarin

HHikma Pharmaceuticals LLC

Phase 3

22

Concerta

Johnson & Johnson

Phase 3

13

Activella

Eli Lilly

Preclinical

24

Estrace

Novo Nordisk

Preclinical

25

Ozempic

Novo Nordisk

Preclinical

16

Galvus

Novartis

Preclinical

17

Depo-Provera

Pfizer

Preclinical

18

Resotran

Takeda

Preclinical

19

Epogen

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Preclinical

110

Marinol

Alnylam Pharmaceuticals

Preclinical

1Show 36 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Safety and Efficacy2 trials

Safety and Efficacy of MTS Versus Concerta in Pediatric Patients (Aged 6-12 Years) With ADHD

Completed·NNoven Therapeutics·Phase 3·NCT00444574·282 enrolled

A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED)

Completed·Merck & Co.·Phase 2·NCT00475735·72 enrolled

Children2 trials

Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD

Completed·UUniversity of Maryland, College Park·Phase 4·NCT00318981·40 enrolled

Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD

Completed·NNoven Therapeutics·Phase 2·NCT00151970·128 enrolled

Attention Deficit Hyperactivity Disorder2 trials

CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in Adults

Completed·Johnson & Johnson·Phase 3·NCT00246207·32 enrolled

Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

Terminated·PPurdue Pharma LP·Phase 4·NCT04507204·267 enrolled

Cognition1 trial

Effects of Methylphenidate on Brain and Cognition in 22q11 Deletion Syndrome

Completed·UUniversity of Geneva, Switzerland·N/A·NCT04647500·45 enrolled

SMA1 trial

A Study to Explore Plasma Levels of CONCERTA, Ritalin-SR and Novo-Methylphenidate ER-C in Healthy Volunteers

Completed·Johnson & Johnson·Phase 1·NCT01118702·30 enrolled

6 more indications

Treatment1 trial

Benefits of ADHD Treatment in Detained People

Recruiting·SStéphanie Baggio·Phase 3·NCT05842330·150 enrolled

Memory1 trial

Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression

Terminated·UUniversity of South Florida·Phase 2·NCT00069927·12 enrolled

Biomarkers1 trial

Biomarkers of ADHD Treatment Response

Completed·—·Phase 1·NCT05650775·16 enrolled

Therapeutics1 trial

Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children.

Recruiting·—·N/A·NCT06369714·210 enrolled

Interaction1 trial

A Drug Interaction Study of SPD503 and Concerta Administered Alone and In Combination in Normal Healthy Volunteers

Completed·Takeda·Phase 1·NCT00901576·38 enrolled

Unspecified1 trial

Concerta (Methylphenidate) -To-Generic Switch Study

Completed·Johnson & Johnson··NCT02730572·1,464 enrolled

Details

Drug Info

Related News